Literature DB >> 26135127

The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD.

L Ambrosio1, G Ambrosio2, G Nicoletti2, G de Crecchio2, B Falsini3.   

Abstract

BACKGROUND: To investigate, in a prospective study, the role of multifocal electroretinography (mfERG) for predicting visual acuity decline in early age-related macular degeneration (AMD) with time.
METHODS: Twenty-six early AMD patients (12 males and 14 females, mean age 66.9 ± 9.8; range 46-82 years) were included in the study. A complete ophthalmic examination and mfERG (Retiscan, Roland Germany, ISCEV standard protocol) were performed at the study entry (baseline), after 20 and 24 months. The first-order kernel mfERG responses were analyzed by ring analysis. The amplitude density (AD) of the first positive peak (P1, nV/deg(2)), the P1 amplitude (µV) and P1 implicit time (ms) for Rings 1 (central) to 6 (most peripheral) were evaluated. Data were statistically analyzed by analysis of variance and receiver operating characteristic (ROC) curves.
RESULTS: The loss in the mfERG Ring 1 AD from normal control values, recorded at baseline, was correlated with the decrease in ETDRS visual acuity with time (P = 0.004). ROC analysis showed that, after 24 months, the average decline in visual acuity was greater (3 letters vs 0.4 letters, P = 0.0021) in patients whose Ring 1 P1 AD at baseline was equal to or less than 65.9 nV/deg(2), compared to those with higher AD values. Both P1 amplitude and AD of Ring 1 had an area under the curve of 0.702 (95% confidence interval 0.50-0.92) with a sensitivity of 64.3% (35.14-87.24%) and a specificity of 91.7% (61.52-99.79%).
CONCLUSIONS: The present results indicate that mfERG P1 amplitude and AD of Ring 1 may be highly specific to predict visual acuity decline in early AMD.

Entities:  

Keywords:  Age-related macular degeneration; Multifocal electroretinography; Progressive retinal degeneration; Visual acuity

Mesh:

Year:  2015        PMID: 26135127     DOI: 10.1007/s10633-015-9507-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  26 in total

Review 1.  Risk factors for age-related macular degeneration.

Authors:  J R Evans
Journal:  Prog Retin Eye Res       Date:  2001-03       Impact factor: 21.198

2.  Loss of cone function in age-related maculopathy.

Authors:  Joanna A Phipps; Robyn H Guymer; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

3.  Preliminary evaluation of flicker sensitivity as a predictive test for exudative age-related maculopathy.

Authors:  M J Mayer; S J Spiegler; B Ward; A Glucs; C B Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-10       Impact factor: 4.799

4.  Foveal flicker sensitivity discriminates ARM-risk from healthy eyes.

Authors:  M J Mayer; S J Spiegler; B Ward; A Glucs; C B Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-10       Impact factor: 4.799

5.  Evaluating retinal function in age-related maculopathy with the ERG photostress test.

Authors:  Alison M Binns; Tom H Margrain
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

6.  Regional cone-mediated dysfunction in age-related maculopathy evaluated by focal electroretinograms: relationship with retinal morphology and perimetric sensitivity.

Authors:  Marco Piccardi; Lucia Ziccardi; Giovanna Stifano; Lucrezia Montrone; Giancarlo Iarossi; Angelo Minnella; Antonello Fadda; Emilio Balestrazzi; Benedetto Falsini
Journal:  Ophthalmic Res       Date:  2009-05-15       Impact factor: 2.892

7.  Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in early age-related macular degeneration.

Authors:  Thomas J Gin; Chi D Luu; Robyn H Guymer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

Review 8.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

9.  Delays in rod-mediated dark adaptation in early age-related maculopathy.

Authors:  C Owsley; G R Jackson; M White; R Feist; D Edwards
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

10.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Authors: 
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

View more
  1 in total

1.  Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial.

Authors:  Geoffrey K Broadhead; John R Grigg; Peter McCluskey; Thomas Hong; Timothy E Schlub; Andrew A Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-20       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.